By Devika Patel
Knoxville, Tenn., Jan. 23 - Ondine Biopharma Corp. announced a C$1.02 million non-brokered private placement of stock.
The company will sell 17 million common shares at C$0.06 per share.
Proceeds will be used for research and development of new products, working capital and general corporate purposes.
Ondine, based in Vancouver, B.C., develops non-antibiotic therapies for the treatment of bacterial, fungal and viral infections.
| Issuer: | Ondine Biopharma Corp.
|
| Issue: | Common shares
|
| Amount: | C$1.02 million
|
| Shares: | 17 million
|
| Price: | C$0.06
|
| Warrants: | No
|
| Agent: | Non-brokered
|
| Pricing date: | Jan. 23
|
| Stock symbol: | Toronto: OBP
|
| Stock price: | C$0.105 at close Jan. 22
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
